PATENT CLAIM ANALYSIS

Application Number: 16221546
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "374000"]

Abstract:
The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.

Claim (Index 15):
The method of  claim 7 , wherein the mammal is a human patient and the therapeutically effective amount of ifetroban improves laboratory and physical evidence of inflammation in the patient compared to placebo as measured by serum biomarkers, erythrocyte sedimentation rate, physical examination, and combinations of any of the foregoing.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 98.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14715143', '15608507', '16004666', '15592727', '10943549']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8211785216201506
- 35 USC 102 Novelty (BERT): 0.5602353731163798
- Combined Prediction Score: 0.7950842067697735
- Mean Citation Score: 404.270682
- Max Citation Score: 466.64432
- Similarity Product: 314.1370900655079

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test